U

University Diabetes and Endocrine Consultants | Chattanooga, TN

Research site

(Unclaimed)

Location

5616 Brainerd Road, Chattanooga, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Glimepiride

LY2963016

Avexitide

LY900014

AG019

Teplizumab

PF-04937319

Selonsertib

Plozasiran

LY2409021

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

Avexitide for Treatment of Post-Bariatric Hypoglycemia (LUCIDITY)

AVX-001 (LUCIDITY) is a Phase 3 study to evaluate avexitide compared to placebo in participants with post bariatric hypoglycemia (PBH) related to Rou...

Active, not recruiting

Post Bariatric Hypoglycemia

Drug: Avexitide

Other: Placebo

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

The purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disp...

Enrolling

Type 1 Diabetes Mellitus

Type 2 Diabetes Mellitus

Device: MiniMed™ NMX8-AID System with DS5™

Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (MUIR-3)

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Active, not recruiting

Hypertriglyceridemia

Drug: Placebo

Drug: Plozasiran Injection